Delivery Order SPE2DB22D1002-SPE2DB24FKYN8

Award Date 2/28/24
Potential Completion Date 2/29/24
Potential Value $2.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,017,426 MENVEO A-C-Y-W KIT (2 VIALS) pharmaceutical products. The contract, valued at $3,860.28, has a performance period through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $1,930.14 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENVEO A-C-Y-W KIT (2 VIALS)S medical supplies. This contract has a performance period through March 8, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued...
This federal contract award is a $3,860.28 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for the supply of the MENVEO A-C-Y-W KIT (2 VIALS)S pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not associated with any set-aside designation. The company also holds an...
The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML. The firm fixed price contract has a potential value of $2,114.19 and a period of performance through February 14, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. The contract is part of a larger DLA...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide MENVEO A-C-Y-W KIT (2 VIALS) pharmaceutical products. The contract has a potential value of $1,608.45 and a completion date of February 1, 2024. This delivery order falls under an indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp as a single awardee, with a...
This firm fixed price delivery order contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $6,433.80 contract is for the provision of MENVEO A-C-Y-W KIT (2 VIALS)S, a pharmaceutical product. The contract has a completion date of February 29, 2024 and was awarded on February 28, 2024. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $6,433.80 by the Defense Logistics Agency (DLA). The award is for the provision of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S, a pharmaceutical product, under a firm fixed price delivery order. The contract has a ceiling value of $3,860.28 and a period of performance through March 13, 2024....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,291.54 Firm Fixed Price Delivery Order covers the supply of 4,566,307,047 MENVEO A-C-Y-W KIT (2 VIALS)S, with a final completion date of November 4, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,357.20, is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S, which are likely medical products or vaccines. The contract is a Firm Fixed Price Delivery Order and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB24FKYN8
    Delivery Order

The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,251.83 contract is for the provision of 4563797875 - MENVEO A-C-Y-W KIT (2 VIALS)S, with a performance period through February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there were no set-aside designations used for this award. This order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This latest award expands Amerisourcebergen Drug Corp's support of critical military healthcare needs through its extensive federal contracting work.

Generated 5/29/24, 10:03 AM